Skylight Health Group Inc. operates as a healthcare services and technology company in the United States, Canada, the United Kingdom, and Colombia. It operates the US multi-state primary care health network that comprises of physical practices, which provides a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The company also owns and operates a proprietary electronic health record system that supports the delivery of care to patients through telemedicine and other remote monitoring system integrations. In addition, it offers a disruptive subscription-based telemedicine service for the un/under-insured population. The company was formerly known as CB2 Insights Inc. and changed its name to Skylight Health Group Inc. in November 2020. Skylight Health Group Inc. was founded in 2014 and is headquartered in Mississauga, Canada.
IPO Year:
Exchange: NASDAQ
Website: skylighthealthgroup.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/4/2022 | Hold → Speculative Buy | Mackie Research | |
| 11/17/2021 | $7.00 → $4.50 | Outperform → Market Perform | Raymond James |
| 10/14/2021 | $9.00 | Outperform | Northland Capital |
| 8/2/2021 | $8.00 | Buy | Lake Street |
Mackie Research upgraded Skylight Health Group from Hold to Speculative Buy
Raymond James downgraded Skylight Health Group from Outperform to Market Perform and set a new price target of $4.50 from $7.00 previously
Northland Capital initiated coverage of Skylight Health Group with a rating of Outperform and set a new price target of $9.00
Lake Street initiated coverage of Skylight Health Group with a rating of Buy and set a new price target of $8.00
15-12G/A - Skylight Health Group Inc. (0001839730) (Filer)
15-12G - Skylight Health Group Inc. (0001839730) (Filer)
6-K - Skylight Health Group Inc. (0001839730) (Filer)
6-K - Skylight Health Group Inc. (0001839730) (Filer)
25 - Skylight Health Group Inc. (0001839730) (Filer)
6-K - Skylight Health Group Inc. (0001839730) (Filer)
6-K - Skylight Health Group Inc. (0001839730) (Filer)
6-K - Skylight Health Group Inc. (0001839730) (Filer)
6-K - Skylight Health Group Inc. (0001839730) (Filer)
6-K - Skylight Health Group Inc. (0001839730) (Filer)
TORONTO, July 14, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced the re-appointment of Co-Founder and current Director and Chief Corporate Officer Kash Qureshi as President. Prad Sekar, CEO and Co-Founder of Skylight Health said, "What has made us resilient in any environment is having both co-founders working side by side for over 12 years. Kash and I will continue to execute our plan to bring Skylight into profitability in 2022. We are fortunate to have an experienced and highly capable senior management team who will continue to lead our
TORONTO, June 29, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, is pleased to announce the results of voting at its annual general meeting of the shareholders which was held today (the "Meeting"). All matters submitted to the shareholders, as set out in the Company's Notice of Meeting and Management Information Circular, were approved by the requisite majority of votes cast at the Meeting. Election of Directors Each of the nominees for election as directors listed in the management information circular of the Corporation dated May 13, 2022, was elected a
TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced the appointment of Mohammad Bataineh as the Company's new President. Brings over 25 years of experience working in primary care, healthcare M&A, integrations, legal and operations;Will be responsible for management and execution of all internal functions including coordination with clinical, financial, and technology teams;Co-Founder Kash Qureshi will shift focus to Corporate Affairs, including Corporate Development, and will retain executive leadership while overseeing the Tec
TORONTO, July 07, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced the appointment of Dr. Kit Brekhus, MD, as Chief Medical Officer (CMO). Dr. Brekhus will be taking the position over from Dr. Georges Feghali who served as CMO from February 2021. Dr. Feghali will continue to serve as an advisor to the Company. As a board-certified family physician, Dr. Brekhus brings a wealth of experience to Skylight Health and a passion for improving patient care. In a career spanning more than 25 years, Dr. Brekhus has worked as both a clinician and owner-o
TORONTO, June 29, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-specialty healthcare systems in the United States, is pleased to announce the results of voting at its annual general meeting of the shareholders which was held today (the "Meeting"). All matters submitted to the shareholders, as set out in the Company's Notice of Meeting and Management Information Circular, were approved by the requisite majority of votes cast at the Meeting. Election of DirectorsShareholders approved the election of the Directors as set out below: Pradyum SekarKashaf QureshiNorton SinghavonGrace MellisTom BroganPeter CumminsPatrick
TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced its financial results for the second quarter ended June 30, 2022. Doubles revenue to $16.1 million vs $7.7 million in the previous quarter and 134% Year over Year.Gross profit margin of 25%, down from the previous quarter of 44% primarily driven by the Capitated revenue from full-risk Value Based Care ("VBC") contracts with the acquisition of NeighborMD ("NMD"). Capitated revenue has lower Gross Margins but much higher dollar contribution.Adjusted EBITDA loss improved by 19% fr
TORONTO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, is pleased to announce that its financial results for the second quarter of 2022 will be released after the close of market on August 15th, 2022. The Company will host a conference call at 8:00am EDT on the morning of August 16, 2022 to discuss the financial results and outlook for the Company. If you would like to participate in the call, details can be found below. Please dial in approximately 10 minutes prior to the start of the call. Conference Call Details Date:August 16, 2022Time:8
TORONTO, July 20, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares (the "Series A Preferred Shares") for the month of August 2022. The Series A Preferred Shares trade under the "SLHGP" stock ticker symbol. In accordance with the terms of the Series A Preferred Shares, the Series A dividend will be payable in cash in the amount of $0.1927 per share on August 22, 2022 to the shareholders of record
TORONTO, June 20, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares (the "Series A Preferred Shares") for the month of July 2022. The Series A Preferred Shares trade under the "SLHGP" stock ticker symbol. In accordance with the terms of the Series A Preferred Shares, the Series A dividend will be payable in cash in the amount of $0.1927 per share on July 20, 2022 to the shareholders of record of
TORONTO, May 20, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares (the "Series A Preferred Shares") for the month of June 2022. The Series A Preferred Shares trade under the "SLHGP" stock ticker symbol. In accordance with the terms of the Series A Preferred Shares, the Series A dividend will be payable in cash in the amount of $0.1927 per share on June 20, 2022 to the shareholders of record of th
TORONTO, May 16, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced its financial results for the first quarter ended March 31, 2022. Strong revenue growth of 255% Year over Year through the continued acquisition of primary care practices.Accelerates its 3-5 year journey to Medicare Advantage ("MA") full risk into 2022 with the acquisition of NeighborMD ("NMD") and the joint venture ("JV") with Collaborative Health Systems ("CHS").Over $70 million revenue run rate on a proforma basis with the acquisition of NMD and before any revenue synergies
TORONTO, May 11, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG;TSXV:SLHG ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced that its financial results for the first quarter of 2022 will be released after the close of market on May 16th, 2022. The Company will host a conference call at 8:00am EDT on the morning of May 17th, 2022 to discuss the financial results and outlook for the Company. If you would like to participate in the call, details can be found below. Please dial in approximately 10 minutes prior to the start of the call. Conference Call Details Date:May 17, 2022Time:8:00am EasternUS/Ca
Skylight executes a definitive agreement for the largest acquisition to date and arranges a US $20 million credit line facility to fund the acquisition and future deals NeighborMD ("NMD") will add 9 practices across Central and Southern Florida with over 2,400 owned and affiliated global capitated risk lives. Unaudited trailing 12 months (TTM) primary care revenue of US $35 million roughly evenly split between owned and affiliate practices; expected to more than double current Skylight revenue run rateArranged US $20 million debt facility with New York-based lenderAddition of a strong management team to bolster current Skylight experience and bring knowledge in delivering against a succes
TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares (the "Series A Preferred Shares") for the month of May 2022. The Series A Preferred Shares trade under the "SLHGP" stock ticker symbol. In accordance with the terms of the Series A Preferred Shares, the Series A dividend will be payable in cash in the amount of $0.1927 per share on May 20, 2022 to the shareholders of record of th
TORONTO, March 30, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced its financial results for the fourth quarter and year ended December 31, 2021, as well as the filing of its restated condensed interim consolidated financial statements and management's discussion and analysis for the quarters ended March 31, 2021, June 30, 2021 and September 30, 2021 (collectively, "restated financial statements and MD&A"). "Our strength as an entrepreneurial team means that we continue to place our efforts where we believe will drive the maximum value for th
TORONTO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG) ("Skylight Health" or the "Company"), a healthcare platform combining technology and analytics focused on transitioning patients into value based care to drive better health outcomes and experiences in the United States, today provides a general corporate update on the status of the Company's initiatives to drive organic growth, continue on its pathway to profitability and expansion of value based care contracts. Over 15% growth in patient visits in August 2022 vs July 2022 driven by newly implemented contact center and other marketing initiatives;Over $10 million reduction from forecasted annual costs driv
TORONTO, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, is pleased to announce that it has closed the non-brokered private placement announced on August 8, 2022 (the "Offering"), issuing 2,355 units of unsecured convertible debentures ("Debentures"). The principal sum of Debentures issued totals C$2,355,000. Prad Sekar, CEO & Co-Founder of Skylight Health said, "We have a strong history of being diligent in our capital raising to ensure minimal dilution, and this cash injection gives us a buffer to get us comfortably to cash flow positivity." The
TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced its financial results for the second quarter ended June 30, 2022. Doubles revenue to $16.1 million vs $7.7 million in the previous quarter and 134% Year over Year.Gross profit margin of 25%, down from the previous quarter of 44% primarily driven by the Capitated revenue from full-risk Value Based Care ("VBC") contracts with the acquisition of NeighborMD ("NMD"). Capitated revenue has lower Gross Margins but much higher dollar contribution.Adjusted EBITDA loss improved by 19% fr
TORONTO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, is pleased to announce that its financial results for the second quarter of 2022 will be released after the close of market on August 15th, 2022. The Company will host a conference call at 8:00am EDT on the morning of August 16, 2022 to discuss the financial results and outlook for the Company. If you would like to participate in the call, details can be found below. Please dial in approximately 10 minutes prior to the start of the call. Conference Call Details Date:August 16, 2022Time:8
TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, has commenced a non-brokered private placement offering (the "Offering") of convertible debenture units (the "Debenture Units") at C$1,000 per Debenture Unit for total gross proceeds of up to C$2 million. Each Debenture shall be in the principal amount of C$1,000 and shall bear interest at the rate of 8% per annum, paid quarterly in shares, and shall have a maturity date of February 15, 2025. Each Debenture shall be convertible into 1,111 common shares of the Company at C$0.90 ("Common Shares"
TORONTO, July 20, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares (the "Series A Preferred Shares") for the month of August 2022. The Series A Preferred Shares trade under the "SLHGP" stock ticker symbol. In accordance with the terms of the Series A Preferred Shares, the Series A dividend will be payable in cash in the amount of $0.1927 per share on August 22, 2022 to the shareholders of record
TORONTO, July 14, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced the re-appointment of Co-Founder and current Director and Chief Corporate Officer Kash Qureshi as President. Prad Sekar, CEO and Co-Founder of Skylight Health said, "What has made us resilient in any environment is having both co-founders working side by side for over 12 years. Kash and I will continue to execute our plan to bring Skylight into profitability in 2022. We are fortunate to have an experienced and highly capable senior management team who will continue to lead our
TORONTO, June 29, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, is pleased to announce the results of voting at its annual general meeting of the shareholders which was held today (the "Meeting"). All matters submitted to the shareholders, as set out in the Company's Notice of Meeting and Management Information Circular, were approved by the requisite majority of votes cast at the Meeting. Election of Directors Each of the nominees for election as directors listed in the management information circular of the Corporation dated May 13, 2022, was elected a
TORONTO, June 23, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced that the Company received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") on June 16, 2022, that the Company is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requiremen
TORONTO, June 20, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares (the "Series A Preferred Shares") for the month of July 2022. The Series A Preferred Shares trade under the "SLHGP" stock ticker symbol. In accordance with the terms of the Series A Preferred Shares, the Series A dividend will be payable in cash in the amount of $0.1927 per share on July 20, 2022 to the shareholders of record of
Gainers Virax Biolabs Group Limited (NASDAQ:VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023. Addex Therapeutics Ltd (NASDAQ:ADXN) gained 110.4% to close at $1.93 after the company issued corporate update and financial guidance. The company announced the reduction of its issued, authorized and conditional share capital from CHF 1.00 to CHF 0.01 and provided corporate updates. 1Life Healthcare, Inc. (NASDAQ:ONEM) gained 69.5% to close at $17.25 after Amazon announced it will acquire the company for $18 per share in an all-cash transaction valu
Gainers Virax Biolabs Group Limited (NASDAQ:VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023. Addex Therapeutics Ltd (NASDAQ:ADXN) jumped 131.1% to $2.12 after the company issued corporate update and financial guidance. 1Life Healthcare, Inc. (NASDAQ:ONEM) gained 68% to $17.10 after Amazon announced it will acquire the company for $18 per share in an all-cash transaction valued at approximately $3.9 billion. Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) shares jumped 47.3% to $3.8299 after the company said it expects Q2 sales of $72 – $73 million, exceeding the
During Tuesday's session, 539 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the biggest company by market cap to set a new 52-week low. The smallest company on a market cap basis to set a new 52-week low was ThermoGenesis Holdings (NASDAQ:THMO). Kalera (NASDAQ:KAL)'s stock dropped the most, trading down 21.6% to reach a new 52-week low. CommScope Hldg Co (NASDAQ:COMM)'s stock made the biggest reversal, trading up 0.0% shortly after dropping to a new 52-week low. Here are all the stocks that set new 52-week lows on Tuesday: Taiwan Semiconductor (NYSE:TSM) stock broke to a new 52-week low of $73.74 on Tuesday. Sha
On Friday, 319 stocks hit new 52-week lows. 52-Week Low Highlights: Taiwan Semiconductor (NYSE:TSM) was the biggest company in terms of market cap to set a new 52-week low. ThermoGenesis Holdings (NASDAQ:THMO) was the smallest company in terms of market cap to set a new 52-week low. CTO Realty Growth (NYSE:CTO)'s stock dropped the most, trading down 66.15% to reach a new 52-week low. Banco Macro (NYSE:BMA) saw the sharpest rebound, as shares ascended 0.0%, reversing after hiting a new 52-week low. On Friday, the following stocks hit new 52-week lows: Taiwan Semiconductor (NYSE:TSM) stock broke to a new 52-week low of $76.50 on Friday. Shares of the company traded down 5.71%.
Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced that the Company received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") on June 16, 2022, that the Company is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a pe
Gainers TherapeuticsMD, Inc. (NASDAQ:TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners. JanOne Inc. (NASDAQ:JAN) gained 66.5% to close at $3.73 after the company announced it sold GeoTraq to SPYR Technologies in a $13.5 million transaction. Mullen Automotive, Inc. (NASDAQ:MULN) jumped 44.9% to settle at $1.40 after the company announced results of its solid-state polymer battery testing with the Battery Innovation Center in Indiana. Studio City International Holdings Limited (NASDAQ:MSC) gained 43.3% to close at $3.21. CatchMark Timber Trust, Inc.
On Friday, 153 companies set new 52-week lows. Areas of Significance In Today's 52-Week Lows: Vodafone Group (NASDAQ:VOD) was the biggest company in terms of market cap to set a new 52-week low. Helius Medical Tech (NASDAQ:HSDT) was the smallest company by market cap to set a new 52-week low. LiqTech International (NASDAQ:LIQT)'s stock dropped the most, trading down 44.42% to reach a new 52-week low. GigaMedia (NASDAQ:GIGM) saw the biggest bounce back on, as shares traded up 0.0% to rebound after it hit its new 52-week low. On Friday, the following stocks hit new 52-week lows: Vodafone Group (NASDAQ:VOD) stock hit a new 52-week low of $14.42. The stock was down 0.61% on the se
Skylight Health Group Inc (NASDAQ:SLHG) has agreed to acquire NeighborMD (NMD) for $8 million. Skylight has also arranged a $20 million debt line facility with a New York-based credit lender. The facility's terms will allow the company to draw down $10 million to fund the NMD acquisition. As of 31 December 2021, Skylight held a cash balance of $11.7 million. Why It Is Important: NMD operates nine owned practices offering primary care services to over 5,000 lives. NMD has over 1,100 Medicare Advantage (MA) lives in full-risk contracts with Humana Inc (NASDAQ:HUM) and CarePlus, in Florida. In addition, NMD provides complete management services for over 1,400 additional MA lives through it